Publication:
Single nucleotide polymorphisms of histamine H4 receptor gene are associated with drug treatment in Thai schizophrenia patients

dc.contributor.authorThongket P.
dc.contributor.authorRattanathanawan K.
dc.contributor.authorThurakitwannakarn W.
dc.contributor.authorSukhumsirichart W.
dc.date.accessioned2021-04-05T03:22:37Z
dc.date.available2021-04-05T03:22:37Z
dc.date.issued2017
dc.date.issuedBE2560
dc.description.abstractBackground: Schizophrenia is a chronic mental disorder characterized by abnormal thoughts, cognition, and social behavior. Genetic and environmental factors contribute to the cause of schizophrenia. The choice of antipsychotics (typical or atypical) used is based on benefits, risks, and costs. Objective: The present study investigated two single nucleotide polymorphisms (SNPs) of the histamine H4 receptor (HH4R) gene in schizophrenia patients who have been treated with typical and atypical drugs. Material and Method: This study was conducted in 60 schizophrenia patients treated with typical antipsychotic (30) and atypical antipsychotic (30) drugs. The DNAs were extracted from whole blood using Flexigene DNA kit (Qiagen, Germany) and genotyped by polymerase chain reaction (PCR) followed by high-resolution melting (HRM) analysis. The difference in genotypic and allelic distribution between patients treated with typical and atypical antipsychotic drugs were assessed by Chi-square test using SPSS software version 11.5. Results: The result revealed that two SNPs (rs8088140 and rs657132) in intronic region of HH4R gene are significant associated with appropriate treatment of schizophrenia patient with typical or atypical antipsychotic drugs. The rs8088140 SNP showed significant at p-value = 0.034, with odd ratio value and 95% CI [2.82 (1.34 to 5.95)], whereas the rs657132 SNP displayed significant at p-value = 0.039, with odd ratio value and 95% CI [2.25 (1.08 to 4.67)]. Conclusion: Two SNPs in HH4R gene (rs8088140 and rs657132) may be used to indicate the proper antipsychotic drugs for treatment of Thai schizophrenia patients. © 2017 Medical Association of Thailand. All rights reserved.
dc.format.mimetypeapplication/pdf
dc.identifier.citationJournal of the Medical Association of Thailand. Vol 100, No.10 (2017), p.S19-S23
dc.identifier.issn1252208
dc.identifier.other2-s2.0-85074973982
dc.identifier.urihttps://hdl.handle.net/20.500.14740/4293
dc.rights.holderScopus
dc.subject.otherAtypical antipsychotic agent
dc.subject.otherChlorpromazine
dc.subject.otherClozapine
dc.subject.otherFluphenazine
dc.subject.otherHaloperidol
dc.subject.otherHistamine H4 receptor
dc.subject.otherNeuroleptic agent
dc.subject.otherPerphenazine
dc.subject.otherRisperidone
dc.subject.otherThioridazine
dc.subject.otherArticle
dc.subject.otherControlled study
dc.subject.otherDNA extraction
dc.subject.otherGene
dc.subject.otherGene frequency
dc.subject.otherGenetic association
dc.subject.otherHigh resolution melting analysis
dc.subject.otherHistamine h4 receptor gene
dc.subject.otherHuman
dc.subject.otherMajor clinical study
dc.subject.otherOdds ratio
dc.subject.otherReal time polymerase chain reaction
dc.subject.otherSchizophrenia
dc.subject.otherSingle nucleotide polymorphism
dc.titleSingle nucleotide polymorphisms of histamine H4 receptor gene are associated with drug treatment in Thai schizophrenia patients
dc.typeArticle
dspace.entity.typePublication
swu.datasource.scopushttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85074973982&partnerID=40&md5=054e2ad73bdb14d67723e93dacfee88f

Files